Control of the renal renin system by local factors  by Wagner, Charlotte et al.
Control of the renal renin system by local factors
CHARLOTTE WAGNER, BOYE L. JENSEN, BERNHARD K. KRA¨MER, and ARMIN KURTZ
Physiologisches Institut und Medizinische Klinik II der Universita¨t Regensburg, Regensburg, Germany
Control of the renal renin system by local factors. Local factors,
such as prostaglandins (PGs), nitric oxide (NO), and endothelins
(ETs), produced in the immediate vicinity of juxtaglomerular (JG)
cells can exert significant effects on renin secretion and renin gene
expression. PGE2, as the main renotubular PG, and PGI2, as the
main endothelial prostanoid, both stimulate renin secretion and
renin gene expression by activating cAMP formation in JG cells.
Although the direct effect of NO on JG cells is less clear, its
overall effect in vivo seems to be to stimulate the renin system.
Evidence is emerging that stimulation by NO is related to the
cAMP pathway, and cGMP-induced inhibition of cAMP-phos-
phodiesterase III (PDE-III) may mediate this effect. ETs, on the
other hand, appear to inhibit the renin system, in particular in
those pathways activated by cAMP, acting via Ca21- and protein
kinase C-related mechanisms. There is increasing evidence that
both NO and PGs could be involved in the physiological regula-
tory mechanisms by which salt intake affects the renin system.
The activity of the renin-angiotensin-aldosterone system,
which plays an essential role in salt and blood pressure
homeostasis in the organism, is governed mainly by the
plasma activity of the protease renin. Although a variety of
tissues can produce renin [1], the major physiological
impact has so far been obtained only for renin of renal
origin. Within the kidney, renin is produced by specialized
vascular smooth muscle cells (VSMCs) of the afferent
arterioles, the so-called granular juxtaglomerular (JG) cells
[2, 3]. The last decade has yielded much information on the
response of renin gene expression and renin secretion
under a variety of physiological and pathophysiological
conditions, and it is clear that renin gene expression and
renin secretion in renal JG cells are influenced to a similar
extent by a number of factors that interact complexly in the
control of the renal renin system [4]. Hypotension is well
known to stimulate renin secretion, and it is generally
agreed that the intraluminal pressure in renal afferent
arterioles is an important determinant, not only for renin
secretion but also for renin gene expression: a low perfu-
sion pressure stimulates and a high pressure suppresses the
renin system. Further evidence suggests that renal perfu-
sion pressure affects the renin system not only by changing
pressures in the afferent vessel wall but also by changing
the glomerular filtration rate (GFR). The GFR is a deter-
minant of the salt load at the macula densa (MD) of the
early distal tubule, and the MD signaling mechanism is also
likely to participate in the mechanisms by which the
intrarenal perfusion pressure controls the renin system [4].
Klaus Thurau developed intriguing and inspiring ideas
about the functional interplay between the tubular MD
cells and the renin-producing JG cells [5]. He proposed a
tubuloglomerular feedback (TGF) linking the tubular salt
load at the early distal tubule to the renal afferent resis-
tance via the renin-angiotensin system. This postulate was
confirmed, almost 30 years later, by Schnermann and
Briggs, who demonstrated the absence of TGF in mice
lacking angiotensin II (Ang II)-AT1a receptors [6], al-
though the precise role of renin in this mechanism is still to
be clarified. There is, however, consensus that decreasing
salt transport at the MD increases renin secretion and renin
gene expression [4]. It is thus conceivable that increasing
renal perfusion pressure might inhibit the renin system also
by increasing GFR and increasing salt delivery to, and
hence transport at, the MD.
Renin gene expression and secretion in vivo also react
sensitively to prolonged changes in salt intake: low salt
intake stimulates and high salt intake suppresses the renin
system [4]. As with the blood pressure, salt intake also
controls the renin system by feedback. The most prominent
feedback mechanism controlling the renin system is medi-
ated by Ang II, which is generated by the successive
proteolytic activities of renin and Ang I-converting enzyme.
Blockade of Ang II-AT1 receptors or diminished Ang II
formation by converting enzyme inhibitors stimulates renin
secretion and renin gene expression powerfully. Con-
versely, Ang II itself inhibits renin secretion in vivo and in
vitro [4].
LOCAL FACTORS CONTROLLING RENIN GENE
EXPRESSION AND SECRETION
Apart from the previously mentioned well-documented
mechanisms controlling the renin system, interest is now
focusing also on the role of local factors for the control of
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the renin system. A role for local factors was, in principle,
already implicit in the influence of the MD on the renin
system, but interest has been restimulated by the observa-
tion that endothelial cells modulate the function of neigh-
boring VSMCs via autacoids such as prostaglandins (PGs),
nitric oxide (NO), endothelins (ETs), endothelium-derived
hyperpolarizing factor. It is now known that synthesis of the
“classic” endothelial autacoids is not restricted to endothe-
lial cells but is found also in several renal cell types. These
autacoids have substantial effects on renin secretion and
renin gene expression, both in vivo and in vitro.
ROLE OF PROSTAGLANDINS IN THE CONTROL OF
THE RENIN SYSTEM
Sites of prostaglandin production in the juxtaglomerular
area
The prerequisite for cell synthesis of PGs and congeners
is the presence of cyclooxygenase (COX), which occurs in
two isoforms (COX-I and -II). Although most cell types
express COX, certain cells, such as the renal proximal
tubule cells, which comprise the bulk of the renal mass, do
not [7]. Within the kidney papillary, interstitial cells have
the highest capacity for PG synthesis [7–9]. PGs of papillary
origin are, however, less likely to be local factors control-
ling renin secretion so that sites of PG formation in the
vicinity of the renin-producing JG cells must be considered.
Afferent arterioles, in fact, are capable of producing PGs
and prostacyclin [10]. It is likely that not only endothelial
cells but also the VSMCs can produce PGs. Glomeruli and
mesangial cells, also close to the JG cells, also synthesize
PGs [11]. Finally, the tubular cells of the late thick ascend-
ing limb of Henle (TALH) including the MD may be
relevant also, as these cells constitutively express relatively
high levels of COX-II [8, 12].
Effect of prostaglandins on renin secretion and renin
gene expression
In vivo experiments show consistently that COX inhibi-
tors, if they affect renin secretion, decrease it, whereas PGs
given into the renal artery stimulate renin secretion. This
suggests that the overall effect of COX products on renin
secretion in vivo is stimulation rather than inhibition [13,
14]. In vitro experiments in isolated perfused kidneys,
isolated glomeruli, and cultured JG cells, moreover, also
indicate that PGE2 and prostacyclin stimulate renin secre-
tion and renin gene expression [15–17]. The stimulatory
effects of PGE2 and prostacyclin in the JG cells appear to
be mediated by stimulation of cAMP formation [17].
Regulation of prostaglandin formation in the
juxtaglomerular region
Prostaglandin formation in renal afferent arterioles and
mesangial cells is stimulated by Ca21 mobilization, such as
by Ang II [10, 11]. Because Ca21-mobilizing hormones, in
particular Ang II, inhibit renin secretion and renin gene
expression [4], it is feasible that increased local PG forma-
tion, at least partly, counteracts the inhibition of renin
secretion and renin gene expression by vasoconstrictors.
More direct evidence for a physiological regulatory role of
PGs has been obtained for the MD mechanism. There it
appears that PGs are, at least in part, required for the
stimulation of renin secretion and renin gene expression via
the MD mechanism [13, 18, 19], findings consistent with the
expression of COX-II in MD cells [12].
A regulatory role is also conceivable for PGs derived
from late TALH cells. COX-II expression in these cells is
strikingly dependent on salt intake, being enhanced by low
salt intake [9, 12] and suppressed by high salt intake [9].
There is in any case evidence that renocortical production
of PGs is inversely related to salt intake [20], suggesting
that tubular PGs could be involved in the stimulation of the
renin system by low salt intake. One study has reported
already that the COX-II—selective inhibitor meloxicam
significantly attenuates the increase of renin mRNA and
renal renin content in response to a low-salt diet in rats
[21].
ROLE OF NITRIC OXIDE IN THE CONTROL OF
RENIN GENE EXPRESSION AND SECRETION
Production sites of nitric oxide in the juxtaglomerular
area
Renal JG cells are surrounded by cells with a high
capacity for NO formation. The endothelial cells of the
afferent arterioles express the endothelial-type NO syn-
thase (e-NOS) [22]. The neighboring tubular cells of the
MD are also a source of NO, because they display a striking
selective expression pattern for the neuronal form of the
NO synthase (n-NOS) [23, 24].
Effect of nitric oxide on renin secretion and renin gene
expression
In vivo experiments in humans and in various animals
species show consistently, with only few exceptions [25, 26],
that inhibitors of NO synthases reduce both plasma renin
activity and renal renin mRNA out of order[20, 27–33].
This inhibition by NO-synthase blockers is enhanced by
prior stimulation of the renin system by various maneuvers
such as renal hypoperfusion [30, 33, 34], low salt intake [27,
28], MD inhibition [20], or Ang II antagonists [29]. These
experiments suggest that endogenous NO is a rather non-
selective stimulator of the renin system. Stimulation of the
renin system by NO is further supported by the observation
that the NO donor nitroprusside increases renin secretion
in vivo [30].
The interpretation of maneuvers interfering with NO in
vivo is, however, hampered by concomitant blood pressure
changes and, hence, activation of cardiovascular reflexes.
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Further experiments have been therefore performed in
models in which the influence of blood pressure or sympa-
thetic nerves are absent or at least well controlled, such as
in isolated perfused kidneys. Findings from this model are
consistent with the in vivo findings in that NO-synthase
inhibitors acutely lower renin secretion, whereas NO do-
nors stimulate renin secretion promptly [35–37]. As in in
vivo studies, the inhibition of renin secretion by NO-
synthase blockers is enhanced if renin secretion is stimu-
lated by reducing perfusion pressure [35], by adding ace-
tylcholine to the perfusate [37], or by taking kidneys from
animals pretreated with a low salt diet [36]. Although all
the in vivo experiments and experiments with isolated
perfused kidney suggest a stimulatory effect of NO on the
renin system, the situation is less clear when the effect of
NO-synthase inhibitors or NO donors in more reduced
preparations, such as, kidney slices, microdissected JG
apparatuses, or isolated JG cells, is considered. In kidney
slices, NO inhibits, whereas NO antagonists stimulate renin
secretion [38, 39]. In microdissected JG apparatuses with
the MD perfused, renin secretion is stimulated when NO
formation in the MD is stimulated but is inhibited when a
NO donor is applied directly to the JG cells [40]. A similar
response is found also in isolated JG cells, in which NO
donors promptly inhibit renin secretion [41, 42]. This
inhibition, however, reverses to stimulation with a delay of
one to two hours [41]. If JG cells are cocultured with
endothelial cells, inhibition of NO release decreases renin
secretion [43].
Taken together, these various findings imply that the
prompt stimulation by NO in vivo and in isolated perfused
kidneys requires mediation by mechanisms that are either
missing or compromised in preparations more reduced
than the isolated perfused kidney. A prime candidate for
such indirect mediation may indeed be the MD mechanism,
as suggested by the experiments with the microdissected JG
apparatuses. However, NO donors also stimulate renin
secretion in hydronephrotic kidneys devoid of MD struc-
tures [37], suggesting that the MD is not essential for the
stimulation of renin secretion by NO. Consistent with this
conclusion are our own data showing that NO donors also
stimulate renin secretion in isolated perfused kidneys with
blocked MD function (Kurtz et al, unpublished data). It
therefore seems unlikely that the presence or absence of an
intact MD can account for the different effects of NO seen
in perfused kidneys and in more reduced preparations.
These discrepancies may be reconciled by considering
the second messenger pathways by which NO acts on the
renin system. Although NO the best established and most
relevant of which is the stimulation of soluble guanylate
cyclase, which leads to increased cGMP synthesis and
hence to increased intracellular cGMP levels. Because
native NO and NO donors also stimulate cGMP formation
in isolated JG cells [41], this classic second messenger
pathway for NO presumably exists in native JG cells. Apart
from direct activation of cation channels (for which there is
no evidence in JG cells), the most characteristic intracellu-
lar action of cGMP is the activation of cGMP-dependent
protein kinases (GK). Two such kinases (GK-I and -II)
have been identified, and interestingly, both are found in
JG cells [44]. Within the kidney, GK-II appears to be
expressed rather selectively in JG cells [45]. GK can be
activated specifically also by membrane-permeable cGMP-
derivatives, such as 8-bromo-cGMP or 8-pCPT-cGMP,
which are also inhibitors of renin secretion in vitro. Thus,
activation of GK by NO may explain inhibition of the renin
system by NO but not the frequently seen stimulation of
renin gene expression and secretion.
A third possibility for the action of NO via cGMP is
inhibition of a specific class of cAMP-phosphodiesterases,
PDE-III [46]. In contrast to the previously mentioned
membrane-permeant cGMP analogs, which have a high
affinity for GK but a very low affinity for PDE-III, native
cGMP has a high affinity for PDE-III. This is important
functionally because increased cGMP could increase
cAMP by inhibiting cAMP degradation and because cAMP
is the best established activator of renin secretion and renin
gene expression [4]. Recently, we have found that pharma-
cological inhibition of PDE-III potently enhances renin
secretion in isolated perfused kidneys (Kurtz et al, unpub-
lished observations). Indirect evidence also suggests a role
for PDE-III in mediating the NO effects on renin secretion
in vivo [47]. Although further experiments are required to
establish firmly the relevance of PDE-III for the effects of
NO on renin secretion and renin gene expression, it should
be remembered that the stimulation of the renin system by
NO is related to the cAMP pathway, as demonstrated in the
isolated perfused kidney (Kurtz et al, unpublished obser-
vations). Because the stability and the expression of PDE-
III in JG cells after isolation are unknown, it is unclear
whether changes of the expression level in vitro can account
for the divergent effects of NO on renin secretion in vitro.
Another possible explanation involving PDE-III is that the
enhancement of cAMP levels by cGMP will depend on the
intrinsic rate of cAMP formation, that is, adenylate cyclase
activity. It is conceivable that in vitro cAMP formation in
JG cells is attenuated because endogenous activators of
cAMP formation, such as PGs, are missing in isolated JG
cells. In this case, activation of GK, and consequently
inhibition of renin secretion, might predominate in the
overall effect of NO on the renin system.
Regulatory role of nitric oxide in the renin system
Given that the overall effect of NO on the renin system
in vivo is stimulation, the question arises as to whether
changes of JG NO formation could be utilized physiologi-
cally to up- or down-regulate renin gene expression and
secretion. NO synthesis in the JG region has not yet been
measured directly. However, n-NOS expression in MD cells
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is clearly up-regulated by salt depletion [48–51]. Given that
the increased expression of n-NOS is associated with
increased NO formation, MD-related changes of NO for-
mation could be a link in the as yet unknown pathway(s) by
which salt deficiency stimulates renin secretion and renin
gene expression. This assumption is supported by the
observation that NOS inhibition blunts the stimulation of
the renin system by low salt intake [27, 28]. MD n-NOS is,
moreover, down-regulated by contralateral renal artery
stenosis [50], a situation that is known to be associated with
suppression of renin secretion and renin m-RNA levels
[34].
There is as yet no evidence for altered e-NOS expression
in the JG region. Assumptions about changes of endothe-
lial NO formation in the JG region therefore derive from
general knowledge about the regulation of NO formation
in endothelial cells. Acetylcholine is a well-known stimula-
tor of NO formation in endothelial cells, and in isolated
kidneys, acetylcholine stimulates renin secretion NO de-
pendently [35, 37].
ROLE OF ENDOTHELIN IN THE CONTROL OF THE
RENIN SYSTEM
Sites of endothelin expression in the juxtaglomerular
area
In contrast to PGs and NO, ET formation has not yet
been localized to the JG region. Medullary collecting duct
cells seem to be a major site of renal ET expression.
Endothelial cells, VSMCs, mesangial, tubular, and even JG
cells themselves may be ET production sites [52, 53]. The
ET family comprises three related peptides (ET-1, -2 and
-3). The kidney only expresses ET-1 and ET-3 [54].
Effects of endothelins on renin secretion and renin gene
expression
In vitro experiments on kidneys slices, isolated glomeruli,
or cultured JG cells show consistently that ETs inhibit renin
secretion and renin gene expression [44, 55–58]. In cultured
mouse JG cells, all three ETs inhibit cAMP-stimulated
renin secretion and renin gene expression equipotently
along an intracellular pathway involving Ca21 and protein
kinase C [44, 58]. In isolated perfused rat kidneys, all three
ETs affect renin secretion equipotently [59]. In picomolar
concentrations, ETs tend to increase renin secretion, but in
the nanomolar range, ETs consistently inhibit renin secre-
tion, as in isolated JG cells. Finally, administration of
pharmacological doses of ETs also inhibits renin secretion
in vivo.
In contrast to the clear effects of exogenous ETs on renin
gene expression and secretion, information on effects of
endogenous ETs on the renin system is scarce. Administra-
tion of effective doses of antagonists for both ETa and ETb
receptors in vivo changes neither plasma renin activity nor
renin mRNA levels [60]. In rats with unilateral renal artery
stenosis, in which the renin system is activated in the
stenosed kidney and suppressed in the intact contralateral
kidney, ET antagonists also do not influence the changes of
plasma renin activity nor the changes of renin mRNA in
either kidney [60].
Regulatory role of endothelins for renin secretion and
renin gene expression
Renal artery stenosis significantly up-regulates ET1 and
ET3 mRNA in the kidney [61]. The inhibition of the renin
system by ET contrasts with the strong stimulation of renin
secretion and renin mRNA in kidneys with stenosed arter-
ies. Enhanced formation of ETs possibly counteracts the
stimulation of the renin system by renal hypoperfusion.
However, as noted earlier here, ET antagonists change
neither renin secretion nor renin mRNA in hypoperfused
kidneys [60].
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